A retrospective analysis of post second-line chemotherapy treatment outcomes for patients with advanced or metastatic cholangiocarcinoma and FGFR2 fusions.

被引：0
|
作者：
Javle, Milind M.
Sadeghi, Saeed
El-Khoueiry, Anthony B.
Goyal, Lipika
Philip, Philip Agop
Kelley, Robin Kate
Borbath, Ivan
Macarulla, Teresa
Yong, Wei-Peng
Tanasanvimon, Suebpong
Pande, Amit
Li, Gary
Howland, Michael
Berman, Craig
Abou-Alfa, Ghassan K.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Calif Los Angeles, Santa Monica, CA USA
[3] USC Kenneth Norris Comprehens Canc Ctr, Los Angeles, CA USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Karmanos Canc Inst, Detroit, MI USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Clin Univ St Luc, Brussels, Belgium
[8] Hosp Valle De Hebron, Barcelona, Spain
[9] Natl Univ Canc Inst, Singapore, Singapore
[10] Chulalongkorn Univ, Bangkok, Thailand
[11] QED Therapeut Inc, San Francisco, CA USA
[12] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4591
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of second-line chemotherapy in patients with advanced or metastatic cholangiocarcinoma and FGFR2 fusions: A retrospective analysis
    Javle, M.
    Sadeghi, S.
    Roychowdhury, S.
    El-Khoueiry, A.
    Goyal, L.
    Philip, P.
    Kelley, R.
    Borbath, I.
    Macarulla, T.
    Yong, W.
    Tanasanvimon, S.
    Li, A.
    Howland, M.
    Pande, A.
    Abou-Alfa, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S219 - S219
  • [2] A pilot study of ponatinib in cholangiocarcinoma patients with FGFR2 fusions.
    DeLeon, Thomas
    Alberts, Steven R.
    McWilliams, Robert R.
    Hubbard, Joleen Marie
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Mody, Kabir
    Roberts, Lewis R.
    Salomao, Marcela
    Kipp, Benjamin
    Halfdanarson, Thorvardur Ragnar
    Murtaza, Muhammed
    Ramanathan, Ramesh K.
    Dueck, Amylou C.
    Borad, Mitesh J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [3] Infigratinib for the Treatment of Metastatic or Locally Advanced Cholangiocarcinoma With Known FGFR2 Gene Fusions or Rearrangements
    White, Kathryn
    Anwar, Ahmed I.
    Jin, Kevin
    Bollich, Victoria
    Kelkar, Rucha A.
    Talbot, Norris C.
    Klapper, Rachel J.
    Ahmadzadeh, Shahab
    Viswanath, Omar
    Varrassi, Giustino
    Shekoohi, Sahar
    Kaye, Alan D.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [4] Indirect treatment comparison of futibatinib with chemotherapy and pemigatinib in cholangiocarcinoma with FGFR2 fusions/rearrangements
    Borad, Mitesh J.
    Paine, Abigail
    Wacheck, Volker
    He, Yaohua
    Kazerooni, Reza
    Salimi, Tehseen
    Bridgewater, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangements
    Walden, Daniel
    Eslinger, Cody
    Bekaii-Saab, Tanios
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [6] SECOND-LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC GASTRIC CANCER: A RETROSPECTIVE ANALYSIS
    Alexandre, Maria Teresa
    Luis, Ana Carla
    Clara, Ana
    Fonseca, Vasco
    Freire, Joao
    Moreira, Antonio
    ANNALS OF ONCOLOGY, 2012, 23 : 49 - 49
  • [7] Natural history of patients with advanced cholangiocarcinoma and FGFR2 gene fusions/rearrangements.
    Shroff, Rachna T.
    Avogadri, Francesca
    Weng, Richard
    Li, Ai
    Dambkowski, Carl L.
    Lamarca, Angela
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [8] FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
    Gandhy, Shruti U.
    Casak, Sandra J.
    Mushti, Sirisha L.
    Cheng, Joyce
    Subramaniam, Sriram
    Zhao, Hong
    Zhao, Miao
    Bi, Youwei
    Liu, Guansheng
    Fan, Jianghong
    Adeniyi, Oluseyi
    Charlab, Rosane
    Kufrin, Dubravka
    Thompson, Matthew D.
    Jarrell, Kristin
    Auth, Doris
    Lemery, Steven J.
    Pazdur, Richard
    Kluetz, Paul G.
    Fashoyin-Aje, Lola A.
    CLINICAL CANCER RESEARCH, 2023, 29 (20) : 4027 - 4031
  • [9] A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
    Ji, Sang Hoon
    Lim, Do Hyoung
    Yi, Seong Yoon
    Kim, Hyo Song
    Jun, Hyun Jung
    Kim, Kyoung Ha
    Chang, Myung Hee
    Park, Min Jae
    Uhm, Ji Eun
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    BMC CANCER, 2009, 9
  • [10] A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
    Sang Hoon Ji
    Do Hyoung Lim
    Seong Yoon Yi
    Hyo Song Kim
    Hyun Jung Jun
    Kyoung Ha Kim
    Myung Hee Chang
    Min Jae Park
    Ji Eun Uhm
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Won Ki Kang
    BMC Cancer, 9
12345